Interviews reveal challenges and opportunities in alternative protein sector, highlighting key trends and future research needs.
Growing global protein demand has fueled innovation and investment in alternative protein (AP) products, including plant-based, fermentation-derived, and cell-cultivated products. Through interviews with AP stakeholders in the United States (U.S.), we explored the sector’s evolution, challenges, opportunities, and trends. Interviewees described a boom from 2009 to 2021 followed by a decline, which the sector is now working to reverse. Achieving taste and price parity, attracting a broad consumer base, producing at scale, and navigating a charged policy environment remain key sector challenges. Looking forward, stakeholders were optimistic, noting opportunities including collaborations within and across sectors; workforce development; innovative financing, scalability models, and products; and increased policy engagement. Findings indicate that the U.S. AP sector is at a critical inflection point. This study points to future research, financing, and innovation that could help AP products become a mainstay in the food system.
No takes yet. Share an insight, caveat, or question.
Wood et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: